MedTrace Logo

Overweight and Obesity in Relation to Type ll Diabetes Melitus

NCT04016012 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2022-09-21

No results posted yet for this study

Summary

The aim of the study is to evaluate the efficacy of local Zambian food in improving metabolic profiles of overweight/obese type ll diabetic patients in Kitwe district

Conditions

  • Diabetes Mellitus, Type 2
  • Overweight and Obesity

Interventions

DIETARY_SUPPLEMENT

Local Zambian Foods

Each week, participants in the intervention group will collect a pack of foodstuffs to last a week from the research site. The packs will be adjusted according to the weight of the participant and daily recommended allowances. Packaging of foodstuffs will be done in the food service lab at the Mukuba University. Instructions on how to prepare and use the food will be given to the participants. All food Items will be labelled diabetic food to avoid intra-household sharing.

Sponsors & Collaborators

  • University of Zambia

    collaborator OTHER

  • Afe Babalola University, Nigeria

    collaborator UNKNOWN

  • Buea University, Cameroon

    collaborator UNKNOWN

  • Sokoine University of Agriculture

    collaborator OTHER

  • Kitwe Teaching Hospital, Zambia

    collaborator UNKNOWN

  • National Science and Technology Council

    collaborator FED

  • Mukuba University

    lead OTHER

Principal Investigators

  • Given Chipili · Mukuba University, Kitwe, Zambia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-30
Primary Completion
2023-09-30
Completion
2023-10-15

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04016012 on ClinicalTrials.gov